Skip to main content
. Author manuscript; available in PMC: 2020 Oct 29.
Published in final edited form as: Clin Cancer Res. 2017 Mar 22;23(15):4163–4169. doi: 10.1158/1078-0432.CCR-16-2658

Table 1.

Patient demographics.

Dose escalation cohorts (n=10) Dose expansion (n=18)
Male 5 8
Female 5 10
Age (years)* 66.8 (47–80) 60.1 (26–90)
Weight (kg)* 76 (47.7–123) 73 (47.7–118.9)
Cycles/Doses of ONC201* 3.2 (1–4) 3.3 (1–14)
Prior therapies* 5.5 (1–10) 6.2 (3–18)
Prior radiation 5 12
Prior surgeries 9 13
*

indicate the mean with the range in parentheses.